147 related articles for article (PubMed ID: 35832043)
1.
Tonneau M; Nolin-Lapalme A; Kazandjian S; Auclin E; Panasci J; Benlaifaoui M; Ponce M; Al-Saleh A; Belkaid W; Naimi S; Mihalcioiu C; Watson I; Bouin M; Miller W; Hudson M; Wong MK; Pezo RC; Turcotte S; Bélanger K; Jamal R; Oster P; Velin D; Richard C; Messaoudene M; Elkrief A; Routy B
Oncoimmunology; 2022; 11(1):2096535. PubMed ID: 35832043
[TBL] [Abstract][Full Text] [Related]
2.
Oster P; Vaillant L; Riva E; McMillan B; Begka C; Truntzer C; Richard C; Leblond MM; Messaoudene M; Machremi E; Limagne E; Ghiringhelli F; Routy B; Verdeil G; Velin D
Gut; 2022 Mar; 71(3):457-466. PubMed ID: 34253574
[TBL] [Abstract][Full Text] [Related]
3. Association of Helicobacter pylori infection with survival outcomes in advanced gastric cancer patients treated with immune checkpoint inhibitors.
Che H; Xiong Q; Ma J; Chen S; Wu H; Xu H; Hou B
BMC Cancer; 2022 Aug; 22(1):904. PubMed ID: 35986342
[TBL] [Abstract][Full Text] [Related]
4. Impact of
Magahis PT; Maron SB; Cowzer D; King S; Schattner M; Janjigian Y; Faleck D; Laszkowska M
J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37899129
[TBL] [Abstract][Full Text] [Related]
5. The eradication of Helicobacter pylori restores rather than disturbs the gastrointestinal microbiota in asymptomatic young adults.
He C; Peng C; Wang H; Ouyang Y; Zhu Z; Shu X; Zhu Y; Lu N
Helicobacter; 2019 Aug; 24(4):e12590. PubMed ID: 31124220
[TBL] [Abstract][Full Text] [Related]
6. Physiologic colonic uptake of
Cvetkovic L; Régis C; Richard C; Derosa L; Leblond A; Malo J; Messaoudene M; Desilets A; Belkaid W; Elkrief A; Routy B; Juneau D
Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1550-1559. PubMed ID: 33128571
[TBL] [Abstract][Full Text] [Related]
7. Impact of
Noori M; Fayyaz F; Rezaei N
Immunotherapy; 2023 Jun; 15(9):657-667. PubMed ID: 37140002
[TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori infection as a potential favorable factor for immune checkpoint inhibitor therapy for gastric cancer.
Zhang MJ; Chen DS; Li S; Chen L; Qi YX; Zhang CJ
Invest New Drugs; 2021 Oct; 39(5):1436-1438. PubMed ID: 33913072
[TBL] [Abstract][Full Text] [Related]
9. Impact of Antibiotics and Proton Pump Inhibitors on Efficacy and Tolerance of Anti-PD-1 Immune Checkpoint Inhibitors.
Giordan Q; Salleron J; Vallance C; Moriana C; Clement-Duchene C
Front Immunol; 2021; 12():716317. PubMed ID: 34777340
[TBL] [Abstract][Full Text] [Related]
10. The Gut Microbiome Associates with Immune Checkpoint Inhibition Outcomes in Patients with Advanced Non-Small Cell Lung Cancer.
Hakozaki T; Richard C; Elkrief A; Hosomi Y; Benlaïfaoui M; Mimpen I; Terrisse S; Derosa L; Zitvogel L; Routy B; Okuma Y
Cancer Immunol Res; 2020 Oct; 8(10):1243-1250. PubMed ID: 32847937
[TBL] [Abstract][Full Text] [Related]
11. Effect of cyclo-oxygenase inhibitor use during checkpoint blockade immunotherapy in patients with metastatic melanoma and non-small cell lung cancer.
Wang SJ; Khullar K; Kim S; Yegya-Raman N; Malhotra J; Groisberg R; Crayton SH; Silk AW; Nosher JL; Gentile MA; Mehnert JM; Jabbour SK
J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33020239
[TBL] [Abstract][Full Text] [Related]
12.
Yang L; Zhang J; Xu J; Wei X; Yang J; Liu Y; Li H; Zhao C; Wang Y; Zhang L; Gai Z
Front Cell Infect Microbiol; 2019; 9():375. PubMed ID: 31781514
[No Abstract] [Full Text] [Related]
13. TIGIT
Tsakmaklis A; Farowski F; Zenner R; Lesker TR; Strowig T; Schlößer H; Lehmann J; von Bergwelt-Baildon M; Mauch C; Schlaak M; Knuever J; Schweinsberg V; Heinzerling LM; Vehreschild MJGT
BMC Cancer; 2023 Nov; 23(1):1160. PubMed ID: 38017389
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of gastric microbiome and metagenomic function in patients with intestinal metaplasia using 16S rRNA gene sequencing.
Park CH; Lee AR; Lee YR; Eun CS; Lee SK; Han DS
Helicobacter; 2019 Feb; 24(1):e12547. PubMed ID: 30440093
[TBL] [Abstract][Full Text] [Related]
15. The effects of antibiotics on the efficacy of immune checkpoint inhibitors in patients with non-small-cell lung cancer differ based on PD-L1 expression.
Ochi N; Ichihara E; Takigawa N; Harada D; Inoue K; Shibayama T; Hosokawa S; Kishino D; Harita S; Oda N; Hara N; Hotta K; Maeda Y; Kiura K
Eur J Cancer; 2021 May; 149():73-81. PubMed ID: 33838391
[TBL] [Abstract][Full Text] [Related]
16. Interaction of bacterial genera associated with therapeutic response to immune checkpoint PD-1 blockade in a United States cohort.
Newsome RC; Gharaibeh RZ; Pierce CM; da Silva WV; Paul S; Hogue SR; Yu Q; Antonia S; Conejo-Garcia JR; Robinson LA; Jobin C
Genome Med; 2022 Mar; 14(1):35. PubMed ID: 35346337
[TBL] [Abstract][Full Text] [Related]
17. Antibiotics impair immune checkpoint inhibitor effectiveness in Hispanic patients with non-small cell lung cancer (AB-CLICaP).
Ruiz-Patiño A; Barrón F; Cardona AF; Corrales L; Mas L; Martín C; Zatarain-Barrón ZL; Recondo G; Ricaurte L; Rojas L; Archila P; Rodríguez J; Sotelo C; Viola L; Vargas C; Carranza H; Otero J; Pino LE; Rolfo C; Rosell R; Arrieta O;
Thorac Cancer; 2020 Sep; 11(9):2552-2560. PubMed ID: 32705787
[TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori infection associates with fecal microbiota composition and diversity.
Frost F; Kacprowski T; Rühlemann M; Bang C; Franke A; Zimmermann K; Nauck M; Völker U; Völzke H; Biffar R; Schulz C; Mayerle J; Weiss FU; Homuth G; Lerch MM
Sci Rep; 2019 Dec; 9(1):20100. PubMed ID: 31882864
[TBL] [Abstract][Full Text] [Related]
19. Cancer Cachexia among Patients with Advanced Non-Small-Cell Lung Cancer on Immunotherapy: An Observational Study with Exploratory Gut Microbiota Analysis.
Hakozaki T; Nolin-Lapalme A; Kogawa M; Okuma Y; Nakamura S; Moreau-Amaru D; Tamura T; Hosomi Y; Takeyama H; Richard C; Hosokawa M; Routy B
Cancers (Basel); 2022 Nov; 14(21):. PubMed ID: 36358821
[TBL] [Abstract][Full Text] [Related]
20. The impact of Helicobacter pylori infection, eradication therapy and probiotic supplementation on gut microenvironment homeostasis: An open-label, randomized clinical trial.
Chen L; Xu W; Lee A; He J; Huang B; Zheng W; Su T; Lai S; Long Y; Chu H; Chen Y; Wang L; Wang K; Si J; Chen S
EBioMedicine; 2018 Sep; 35():87-96. PubMed ID: 30145102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
